European Commission Issues New Guidelines On The Formalized Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients
Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
On March 19, 2015, the European Commission issued new guidelines on risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use.
European UnionFood, Drugs, Healthcare, Life Sciences
On March 19, 2015, the European Commission issued new guidelines on risk assessment for
ascertaining the appropriate good manufacturing practice for
excipients of medicinal products for human use. The risk assessment
as set out in these guidelines should be carried out for excipients
for authorized medicinal products for human use by March 21,
2016.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.